Association of N-terminal pro-brain natriuretic peptide level with adverse outcomes in patients with acute myocardial infarction: A meta-analysis

Despite progress in reperfusion therapy, acute myocardial infarction (AMI) is still a leading cause of morbidity and death worldwide.1 Based on the electrocardiogram change, AMI can be grouped into ST-segment elevation myocardial infarction (STEMI) and non –ST-segment elevation myocardial infarction (NSTEMI). Survivors of AMI are at high risk of cardiovascular events and death than the general population.2 Incidence of in-hospital and 1-year death after STEMI was approximately 5 to 6% and 7 to 18%.
Source: Heart and Lung - Category: Intensive Care Authors: Source Type: research